Celemics, Inc. is based in South Korea, with the head office in Seoul. The company operates in the In-Vitro Diagnostic Substance Manufacturing sector. It was first established on November 29, 2010. Celemics, Inc. currently employs 42 (2024) people. From the latest financial highlights, Celemics, Inc. reported a net sales revenue increase of 2.15% in 2024. A growth of 62.34% was recorded in its total assets.

Headquarters
19F ~ 20F, Bldg. A, Byc Highcity, 131, Gasandigital 1-Ro, Geumcheon-Gu
Seoul; Seoul;

Contact Details: Purchase the Celemics, Inc. report to view the information.

Website: http://www.celemics.com

Basic Information

Total Employees:

Purchase the Celemics, Inc. report to view the information.

Outstanding Shares:

Purchase the Celemics, Inc. report to view the information.

Registered Capital:

Purchase the Celemics, Inc. report to view the information.

Financial Auditors:

Purchase the Celemics, Inc. report to view the information.

Incorporation Date:

November 29, 2010

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Subsidiaries

(주)아이엠비디엑스

Company Performance

Financial values in the chart are available after Celemics, Inc. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

2.15%▲

Total Operating Revenue

1.97%▲

Operating Profit

67%▲

EBITDA

77.4%▲

Net Profit/Loss for the Period

N/A

Total Assets

62.34%▲

Total Equity

71.16%▲

Operating Profit Margin

59.24%▲

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Debt / Equity

-3.55%▼

Quick Ratio

-1.57%▼

Cash Ratio

0.44%▲

Celemics, Inc. (South Korea)